These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2261677)

  • 21. Platelet-activating factor antagonists in experimental shock.
    Muacevic G; Heuer HO
    Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y; Imanishi N; Koike H; Morooka S
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
    Wu MS; Biftu T; Doebber TW
    J Pharmacol Exp Ther; 1986 Dec; 239(3):841-5. PubMed ID: 3795043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of endotoxin and platelet-activating factor on lipid oxidation in the rat heart.
    Wang X; Evans RD
    J Mol Cell Cardiol; 1997 Jul; 29(7):1915-26. PubMed ID: 9236145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
    Jakubowski A; Olszanecki R; Chlopicki S
    J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The thrombocyte-activation factor and endotoxin-induced thrombocyte activation].
    Lomazova KD; Poliakova AM; Astrina OS; Tsukerman DB
    Biull Eksp Biol Med; 1989 May; 107(5):538-40. PubMed ID: 2500157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
    Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
    Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO; Letts G; Meade CJ
    J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endotoxin-induced impairment of vascular reactivity in the pithed rat: role of arachidonic acid metabolites.
    Gray GA; Furman BL; Parratt JR
    Circ Shock; 1990 Aug; 31(4):395-406. PubMed ID: 1697789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes.
    Osterud B
    J Leukoc Biol; 1992 May; 51(5):462-5. PubMed ID: 1602239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles.
    Teng CM; Yu SM; Ko FN; Chen CC; Wang WC; Chen KY; Huang YL; Huang TF
    Eur J Pharmacol; 1991 Nov; 205(2):151-6. PubMed ID: 1812005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of platelet-activating factor on rat mesenteric microcirculation.
    Li SH; Gong XQ; Fei X; Wu ZL
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):344-6. PubMed ID: 2104488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge.
    Corl CM; Contreras GA; Sordillo LM
    Vet Immunol Immunopathol; 2010 Jul; 136(1-2):98-107. PubMed ID: 20359754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
    Rabinovici R; Esser KM; Lysko PG; Yue TL; Griswold DE; Hillegass LM; Bugelski PJ; Hallenbeck JM; Feuerstein G
    Circ Res; 1991 Jul; 69(1):12-25. PubMed ID: 1647275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of platelet activating factor on the cerebrovascular permeability in rats and the protection by drug].
    Sun DX; Huang TG; Zeng GQ; Zhu J; Ju DW; Rui YC
    Yao Xue Xue Bao; 1992; 27(9):651-5. PubMed ID: 1293934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mono-hydroxyeicosatetraenoic acids during porcine endotoxemia. Effect of a platelet-activating factor receptor antagonist.
    Olson NC; Joyce PB; Fleisher LN
    Lab Invest; 1990 Aug; 63(2):221-32. PubMed ID: 2116563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
    Chang SW; Feddersen CO; Henson PM; Voelkel NF
    J Clin Invest; 1987 May; 79(5):1498-509. PubMed ID: 3553241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.